BioSig Technologies, Inc. STEX Investment Acquired Through Issuance Of Common Stock
Investment Acquired Through Issuance Of Common Stock at other companies
Other financials
Where this comes from
Reported directly by BioSig Technologies, Inc. in its filing.
Tagged under the XBRL concept STEX:InvestmentAcquiredThroughIssuanceOfCommonStock.
The official record: BioSig Technologies, Inc.’s 10-K, filed March 31, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioSig Technologies, Inc.'s investment acquired through issuance of common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioSig Technologies, Inc.'s investment acquired through issuance of common stock?
- BioSig Technologies, Inc. (STEX) reported investment acquired through issuance of common stock of $2.62M in Q4 2025.
- What does investment acquired through issuance of common stock mean?
- Captures the value of strategic investments or assets acquired by issuing equity instead of cash. This metric is a key indicator of the company's ability to execute inorganic growth or asset acquisition strategies while preserving cash liquidity. It reflects the dilution impact on existing shareholders in exchange for expanding the company's asset base.